
Matt Hewitt
Stock Analyst at Craig-Hallum
(4.45)
# 1,196
Out of 5,152 analysts
730
Total ratings
47.6%
Success rate
8%
Average return
Main Sectors:
Stocks Rated by Matt Hewitt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INFU InfuSystem Holdings | Reiterated: Buy | $18 | $14.67 | +22.70% | 22 | Nov 11, 2026 | |
| CYRX Cryoport | Reiterated: Buy | $20 → $22 | $20.17 | +9.07% | 10 | Nov 6, 2026 | |
| MRVI Maravai LifeSciences Holdings | Reiterated: Buy | $10 | $7.38 | +35.50% | 33 | Nov 5, 2026 | |
| HSTM HealthStream | Downgraded: Hold | $40 | $27.18 | +47.17% | 31 | Nov 3, 2026 | |
| QTI QT Imaging Holdings | Initiated Coverage: Buy | $8 | $1.71 | +367.84% | 1 | Oct 5, 2026 | |
| BHST BioHarvest Sciences | Reiterated: Buy | n/a | $1.23 | - | 20 | Sep 29, 2026 | |
| LFCR Lifecore Biomedical | Downgraded: Hold | $6.28 | $6.40 | -1.88% | 40 | Sep 29, 2026 | |
| OABI OmniAb | Reiterated: Buy | n/a | $5.08 | - | 32 | Sep 29, 2026 | |
| RGEN Repligen | Reiterated: Buy | n/a | $172.67 | - | 58 | Sep 25, 2026 | |
| LGND Ligand Pharmaceuticals | Rated: Buy | n/a | $298.71 | - | 72 | Sep 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $18.97 | - | 9 | Sep 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.15 | - | 53 | Sep 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $7.88 | - | 22 | Sep 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $34.66 | - | 49 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.3201 | +1,149.61% | 14 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $11.18 | - | 18 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $27.20 | - | 52 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.25 | - | 36 | Jul 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.25 | - | 2 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $2.49 | +140.96% | 55 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.1215 | - | 1 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $72.88 | - | 1 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $4.44 | +170.27% | 20 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.22 | - | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.17 | n/a | 12 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $17.90 | n/a | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $15.29 | n/a | 13 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $0.3851 | n/a | 2 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.5331 | n/a | 15 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6 | $2.30 | n/a | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $5.59 | n/a | 1 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.06 | n/a | 22 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 → $17 | $11.32 | n/a | 2 | Oct 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $100 | $0.0002 | n/a | 1 | Jan 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $215 → $154 | $72.75 | n/a | 3 | Oct 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $3.18 | n/a | 4 | Feb 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $50 | $122.86 | n/a | 1 | Nov 8, 2017 |
InfuSystem Holdings
Nov 11, 2026
Reiterated: Buy
Price Target: $18
Current: $14.67
Upside: +22.70%
Cryoport
Nov 6, 2026
Reiterated: Buy
Price Target: $20 → $22
Current: $20.17
Upside: +9.07%
Maravai LifeSciences Holdings
Nov 5, 2026
Reiterated: Buy
Price Target: $10
Current: $7.38
Upside: +35.50%
HealthStream
Nov 3, 2026
Downgraded: Hold
Price Target: $40
Current: $27.18
Upside: +47.17%
QT Imaging Holdings
Oct 5, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $1.71
Upside: +367.84%
BioHarvest Sciences
Sep 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.23
Upside: -
Lifecore Biomedical
Sep 29, 2026
Downgraded: Hold
Price Target: $6.28
Current: $6.40
Upside: -1.88%
OmniAb
Sep 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $5.08
Upside: -
Repligen
Sep 25, 2026
Reiterated: Buy
Price Target: n/a
Current: $172.67
Upside: -
Ligand Pharmaceuticals
Sep 24, 2026
Rated: Buy
Price Target: n/a
Current: $298.71
Upside: -
Sep 24, 2026
Reiterated: Buy
Price Target: n/a
Current: $18.97
Upside: -
Sep 22, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.15
Upside: -
Sep 17, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.88
Upside: -
Sep 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $34.66
Upside: -
Aug 13, 2026
Reiterated: Buy
Price Target: $4
Current: $0.3201
Upside: +1,149.61%
Aug 4, 2026
Reiterated: Hold
Price Target: n/a
Current: $11.18
Upside: -
Jul 8, 2026
Reiterated: Buy
Price Target: n/a
Current: $27.20
Upside: -
Jul 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.25
Upside: -
Jun 2, 2026
Reiterated: Hold
Price Target: n/a
Current: $4.25
Upside: -
May 8, 2026
Reiterated: Buy
Price Target: $6
Current: $2.49
Upside: +140.96%
Mar 25, 2026
Reiterated: Buy
Price Target: n/a
Current: $0.1215
Upside: -
Feb 23, 2026
Reiterated: Buy
Price Target: n/a
Current: $72.88
Upside: -
Dec 16, 2025
Reiterated: Buy
Price Target: $12
Current: $4.44
Upside: +170.27%
Dec 9, 2025
Reiterated: Buy
Price Target: n/a
Current: $1.22
Upside: -
Oct 10, 2025
Reiterated: Buy
Price Target: n/a
Current: $4.17
Upside: n/a
Jun 17, 2025
Rated: Hold
Price Target: n/a
Current: $17.90
Upside: n/a
Apr 25, 2025
Reiterated: Buy
Price Target: n/a
Current: $15.29
Upside: n/a
Dec 18, 2024
Rated: Buy
Price Target: n/a
Current: $0.3851
Upside: n/a
Aug 7, 2024
Reiterated: Buy
Price Target: n/a
Current: $0.5331
Upside: n/a
Feb 9, 2024
Rated: Buy
Price Target: $6
Current: $2.30
Upside: n/a
Sep 21, 2023
Reiterated: Buy
Price Target: n/a
Current: $5.59
Upside: n/a
Feb 23, 2023
Rated: Hold
Price Target: n/a
Current: $8.06
Upside: n/a
Oct 4, 2019
Reiterated: Hold
Price Target: $16 → $17
Current: $11.32
Upside: n/a
Jan 18, 2019
Reiterated: Hold
Price Target: $100
Current: $0.0002
Upside: n/a
Oct 31, 2018
Downgraded: Hold
Price Target: $215 → $154
Current: $72.75
Upside: n/a
Feb 27, 2018
Reiterated: Buy
Price Target: $19
Current: $3.18
Upside: n/a
Nov 8, 2017
Reiterated: Hold
Price Target: $50
Current: $122.86
Upside: n/a